These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 1588740

  • 21. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R, Schleusser B, Herborn G, Karger T.
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [Abstract] [Full Text] [Related]

  • 22. Gold vs D-penicillamine double blind study and followup.
    Thomas MH, Rothermich NO, Philips VK, Bergen W, Hedrick SW.
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [Abstract] [Full Text] [Related]

  • 23. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T, Stambuk B.
    Reumatizam; 1998 Dec; 46(1):7-19. PubMed ID: 9921004
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Long-term comparative studies on gold, D-penicillamine, and NSAIDs for the treatment of early rheumatoid arthritis. 1. Evaluation of one year's treatment].
    Azuma T, Sugawara S, Maeda A, Miyauchi T, Aritomi H.
    Ryumachi; 1986 Jun; 26(3):200-9. PubMed ID: 3097838
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J.
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
    Schiff MH, Whelton A.
    Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A, Anastassiades T.
    Clin Invest Med; 1984 Dec; 7(1):65-71. PubMed ID: 6426836
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Drugs in the management of rheumatoid arthritis.
    Bresnihan B.
    Ir Med J; 1982 Jan; 75(1):7-9. PubMed ID: 6806208
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P, Menard H, Thompson J, Harth M, Beaudet F.
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.